Adding radial shock wave therapy to physical therapy for chronic low back pain
Official title: The Effect of Extracorporeal Shock Wave Therapy (ESWT) Added to Conservative Treatment on Pain, Disability, and Ultrasonographic Outcomes in Chronic Low Back Pain: A Randomized Controlled Trial
Run by Pamukkale University · NCT07132762 · Data updated 2026-11-12
This study tests whether adding radial extracorporeal shock wave therapy (ESWT) to standard physical therapy helps adults with chronic low back pain reduce pain, disability, and change ultrasound measures of back muscles.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 44 (estimated) |
| Sponsor | Pamukkale University Academic / other |
| Locations | 1 site (Denizli) |
| Status | Recruiting |
| Started | October 10, 2025 |
| Main results expected | July 15, 2026 |
| Study ends | September 15, 2026 |
| Registry record updated | February 6, 2026 |
| Trial ID | NCT07132762 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older with non-specific low back pain lasting more than three months are the intended participants.
✕Probably not a fit
Patients with specific lumbar spine diseases (for example radicular pain or spinal stenosis), prior lumbar surgery or trauma, systemic muscle disorders, coagulopathy, pregnancy, active malignancy, or other listed exclusions are unlikely to benefit or will be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults with non-specific chronic low back pain will receive conventional rehabilitation, and a group will also receive radial ESWT added to that program. Pain, disability questionnaires, and ultrasonographic measures including elastography of paraspinal muscles will be recorded at baseline and after the intervention. The trial compares changes between the group receiving ESWT plus rehab and the group receiving rehab alone to determine added effects. Outcomes will focus on patient-reported pain and function together with imaging-based muscle stiffness and morphology.
Why it matters
Potential benefit: If successful, adding ESWT could reduce pain and disability and improve back muscle function and ultrasound markers, helping patients resume daily activities more easily.
How similar studies have gone: ESWT has produced positive results in some other musculoskeletal conditions but evidence for chronic low back pain is limited and mixed, so this application is relatively novel with preliminary support.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Non-specific low back pain lasting more than three months Exclusion Criteria: * Specific lumbar spine diseases (radicular pain, spinal stenosis, infection) * History of trauma, fracture, surgery, or presence of scar tissue in the lumbar region * Presence of a disease that may affect muscle stiffness, such as collagen tissue disorders, hemiplegia, multiple sclerosis, or myopathies * Malignancy, pregnancy, severe hypertension * Coagulopathy, chronic heart disease * Ankylosing spondylitis * Diseases that may initially affect lumbar mobility and pain, such as leg length discrepancy, hip prosthesis, or scoliosis
Where it's running
-
Pamukkale University
Denizli, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Füsun Ardıç, Professor
- Email: ardicf@gmail.com
- Phone: +905342197714
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Ultrasound-Guided Thoracolumbar Fascia Injection for Chronic Low Back Pain in Type 2 Diabetes
This trial tests whether an ultrasound-guided injection into the thoracolumbar fascia, added to standard care, helps reduce chronic low back pain in adults with type 2 diabetes.
-
Subcutaneous Fat, Back Muscles, and Spine Shape in Back Pain Patients
This study tests whether body fat under the skin and features of back muscles and spine joints are linked to lumbar facet joint degeneration in adults with chronic low back pain.
-
See if serum BDNF levels relate to outcomes in chronic low back pain
This study tests whether blood BDNF levels can help predict how patients with chronic low back pain will do over time.
-
Correlating periostin levels with spinal degeneration in back pain
This study tests whether periostin levels in the intervertebral disc relate to the severity of disc degeneration in people with chronic low back pain and spinal stenosis.
-
Palmitoylethanolamide for Central Sensitisation and Neuroinflammation in Chronic Low Back Pain
A treatment with palmitoylethanolamide is being tried to see if it helps people with chronic low back pain who have nerve-related pain and disc problems.
-
Multichannel neuromuscular stimulation plus core exercise for chronic low back pain
This study tests two multichannel neuromuscular electrical stimulation programs added to a core exercise plan to see if they help adults with chronic non-specific low back pain.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.